CN101401955A - Method for producing nano-fibre bracket material with levorotation polylactic acid as base material - Google Patents
Method for producing nano-fibre bracket material with levorotation polylactic acid as base material Download PDFInfo
- Publication number
- CN101401955A CN101401955A CN 200810235160 CN200810235160A CN101401955A CN 101401955 A CN101401955 A CN 101401955A CN 200810235160 CN200810235160 CN 200810235160 CN 200810235160 A CN200810235160 A CN 200810235160A CN 101401955 A CN101401955 A CN 101401955A
- Authority
- CN
- China
- Prior art keywords
- polylactic acid
- solution
- nanofiber
- matrix
- electrospinning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920000747 poly(lactic acid) Polymers 0.000 title claims abstract description 33
- 239000004626 polylactic acid Substances 0.000 title claims abstract description 33
- 239000000463 material Substances 0.000 title claims abstract description 30
- 239000002121 nanofiber Substances 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000000243 solution Substances 0.000 claims abstract description 27
- 239000000835 fiber Substances 0.000 claims abstract description 20
- 239000002062 molecular scaffold Substances 0.000 claims abstract description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011521 glass Substances 0.000 claims abstract description 12
- 239000011159 matrix material Substances 0.000 claims abstract description 12
- 238000001523 electrospinning Methods 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 238000005516 engineering process Methods 0.000 claims abstract description 8
- 239000011259 mixed solution Substances 0.000 claims abstract description 6
- 230000004048 modification Effects 0.000 claims abstract description 6
- 238000012986 modification Methods 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims description 9
- 102000012422 Collagen Type I Human genes 0.000 claims description 4
- 108010022452 Collagen Type I Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000009832 plasma treatment Methods 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- 238000003760 magnetic stirring Methods 0.000 claims description 2
- 229920001432 poly(L-lactide) Polymers 0.000 abstract description 13
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 abstract description 7
- 230000015556 catabolic process Effects 0.000 abstract description 4
- 238000006731 degradation reaction Methods 0.000 abstract description 4
- 230000007547 defect Effects 0.000 abstract description 3
- 230000035699 permeability Effects 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 239000007857 degradation product Substances 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 1
- 238000009987 spinning Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 210000001178 neural stem cell Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007646 directional migration Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000002241 neurite Anatomy 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001248 thermal gelation Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Nonwoven Fabrics (AREA)
Abstract
本发明涉及以左旋聚乳酸为基质的纳米纤维支架材料的制备方法。本发明将左旋聚乳酸为基质溶解于二氯甲烷与二甲基甲酰胺溶液中,搅拌、离心得静电纺丝溶液;再置聚乳酸溶液于5ml的玻璃注射器中,加高电压;推进玻璃注射器中的左旋聚乳酸溶液;利用静电纺丝技术将此混合溶液制备成纳米纤维材料膜;改性处理得纳米纤维支架材料,其纤维直径在50nm-500nm,纤维孔隙率>90%。本发明解决了PLLA多孔支架仍然存在着降解时间过长,降解产物易引起组织炎症等缺陷。本发明具有质地柔韧,具有较好的透水透气性能,优良的组织相容性、可控生物降解性、无抗原性。
The invention relates to a preparation method of a nanofiber scaffold material with L-polylactic acid as a matrix. In the present invention, L-polylactic acid is dissolved as a matrix in methylene chloride and dimethylformamide solution, stirred and centrifuged to obtain an electrospinning solution; the polylactic acid solution is then placed in a 5ml glass syringe, and a high voltage is applied; the glass syringe is advanced L-polylactic acid solution in the mixture; the mixed solution is prepared into a nanofiber material film by electrospinning technology; the nanofiber scaffold material is obtained through modification, the fiber diameter is 50nm-500nm, and the fiber porosity is >90%. The invention solves the defects that the PLLA porous scaffold still has too long degradation time, and degradation products easily cause tissue inflammation and the like. The invention has flexible texture, good water and air permeability, excellent tissue compatibility, controllable biodegradability and no antigenicity.
Description
技术领域 technical field
本发明涉及一种组织修复材料制备,特别涉及以左旋聚乳酸为基质的纳米纤维支架材料的制备方法。The invention relates to the preparation of a tissue repair material, in particular to a preparation method of a nanofiber scaffold material with L-polylactic acid as a matrix.
背景技术 Background technique
左旋聚乳酸(PLLA)属于α-聚酯类,其体内降解的最终代谢产物为CO2和H2O,不在体内蓄积,几乎没有毒副作用,因其可靠的生物安全性、可降解性、降解可调性、无抗原性等特征,现已经被广泛应用于组织工程学及医学领域中。Poly-L-lactic acid (PLLA) belongs to α-polyesters, and the final metabolites of its degradation in vivo are CO 2 and H 2 O, which do not accumulate in the body and have almost no toxic and side effects, because of its reliable biological safety, degradability, degradation Features such as adjustability and non-antigenicity have been widely used in the fields of tissue engineering and medicine.
在本发明之前,利用热致凝胶化技术制备PLLA多孔支架,和天然细胞间质的结构相似,在支架上进行神经干细胞的体外培养实验,神经干细胞能在支架上分化,且能促进神经突的生长。利用热诱导相分离技术并通过添加PEG-PLLA制备PLLA多孔支架,得到的孔规整且高度相连,孔径很容易控制,用于培养MC3T3-E1细胞,4星期后细胞成功增殖。Before the present invention, the PLLA porous scaffold was prepared by thermal gelation technology, which was similar to the structure of natural interstitial cells, and the in vitro culture experiment of neural stem cells was carried out on the scaffold, and the neural stem cells could differentiate on the scaffold, and can promote neurites growth. Using heat-induced phase separation technology and adding PEG-PLLA to prepare PLLA porous scaffolds, the obtained pores are regular and highly connected, and the pore size is easy to control. They were used to culture MC3T3-E1 cells, and the cells proliferated successfully after 4 weeks.
但是,上述PLLA多孔支架仍然存在着降解时间过长,降解产物易引起组织炎症等缺陷,无法广泛应用。However, the above-mentioned PLLA porous scaffold still has defects such as too long degradation time and degradation products that easily cause tissue inflammation, so it cannot be widely used.
发明内容 Contents of the invention
本发明的目的就在于克服上述缺陷,提供一种以左旋聚乳酸为基质的纳米纤维支架材料的制备方法。The object of the present invention is to overcome the above-mentioned defects and provide a method for preparing a nanofibrous scaffold material based on L-polylactic acid.
本发明的技术方案是:Technical scheme of the present invention is:
以左旋聚乳酸为基质的纳米纤维支架材料,其主要技术特征在于以左旋聚乳酸为基质,通过静电纺丝,得纳米纤维支架材料,其纤维直径在50nm-500nm,纤维孔隙率>90%。The main technical feature of the nanofiber scaffold material with L-polylactic acid as the matrix is that the nanofiber scaffold material is obtained by electrospinning with the L-polylactic acid as the matrix, and the fiber diameter is 50nm-500nm, and the fiber porosity is >90%.
本发明的另一技术方案是:Another technical solution of the present invention is:
以左旋聚乳酸为基质的纳米纤维支架材料制备方法,其主要技术步骤在于:The preparation method of the nanofibrous scaffold material with L-polylactic acid as the matrix, the main technical steps are:
(1)将左旋聚乳酸为基质溶解于体积比为3∶1的二氯甲烷与二甲基甲酰胺混合溶液中,磁力搅拌,离心以去除溶液中的气泡,得静电纺丝溶液;(1) dissolving L-polylactic acid as a matrix in a mixed solution of dichloromethane and dimethylformamide with a volume ratio of 3:1, magnetic stirring, and centrifugation to remove air bubbles in the solution to obtain an electrospinning solution;
(2)再置聚乳酸溶液于5ml的玻璃注射器中,在针头处加10kv的高电压;(2) Place the polylactic acid solution in a 5ml glass syringe, and apply a high voltage of 10kv to the needle;
(3)以0.5ml/h的速度推进玻璃注射器中的左旋聚乳酸溶液;(3) advance the L-polylactic acid solution in the glass syringe at a speed of 0.5ml/h;
(4)高速旋转的金属丝滚筒接收器与针头间的距离保持在15~20cm之间,利用静电纺丝技术将此混合溶液制备成纳米纤维材料膜;(4) The distance between the high-speed rotating wire drum receiver and the needle is kept between 15-20 cm, and the mixed solution is prepared into a nanofiber material film by electrospinning technology;
(5)改性处理:将所得的纳米纤维材料膜放入等离子体处理仪中,反应条件设定为放电功率40W,NH3气流量20ml/min,压力20Pa,处理时间40S;将等离子体处理过的纳米纤维材料膜浸入浓度为3mg/ml的I型胶原溶液反应,反复用去离子水清洗后浸泡,除去表面物理吸附的胶原蛋白,将左旋聚乳酸电纺纤维真空干燥,得纳米纤维支架材料。(5) Modification treatment: put the obtained nanofiber material film into a plasma treatment apparatus, and the reaction conditions are set as discharge power 40W, NH gas flow rate 20ml/min, pressure 20Pa, and treatment time 40S; The processed nanofiber material membrane was immersed in the type I collagen solution with a concentration of 3mg/ml to react, and was repeatedly washed with deionized water and soaked to remove the physically adsorbed collagen on the surface, and the L-polylactic acid electrospun fiber was vacuum-dried to obtain a nanofiber scaffold Material.
本发明的优点和效果在于制成直径在50nm-500nm,孔隙率>90%纳米超级有序纤维,质地柔韧,具有较好的透水透气性能,优良的组织相容性、可控生物降解性、无抗原性。The advantages and effects of the present invention are that the diameter is 50nm-500nm, the porosity > 90% nanometer super ordered fiber, the texture is flexible, has good water permeability and air permeability, excellent tissue compatibility, controllable biodegradability, Non-antigenic.
本发明还具有制备工艺简单、成本低,可实现大量生产。所制得的左旋聚乳酸(PLLA)纳米超级有序纤维支架材料能够明显促进细胞的黏附、定向迁移、生长和增殖,具有优良的生物相容性和力学性能,材料性质稳定,使用中无不安全因素产生,常规的消毒和储存不会破坏其结构和性能。The invention also has the advantages of simple preparation process and low cost, and can realize mass production. The prepared poly-L-lactic acid (PLLA) nano-super-ordered fiber scaffold material can significantly promote cell adhesion, directional migration, growth and proliferation, has excellent biocompatibility and mechanical properties, stable material properties, and is safe to use Factors produced, conventional disinfection and storage will not destroy its structure and performance.
本发明的其他优点和效果将在下面继续描述。Other advantages and effects of the present invention will be described below.
附图说明 Description of drawings
图1--本发明的静电纺丝原理示意图(平板接收器1、接受器移动方向2、高压电源3、纺丝溶液4、驱动装置5)。Fig. 1 --Schematic diagram of the electrospinning principle of the present invention (flat receiver 1, receiver moving direction 2, high voltage power supply 3, spinning solution 4, driving device 5).
图2--本发明中滚筒纺丝收集装置示意图(绝缘高速滚筒6、高速马达7、高压电源3、纺丝溶液4、驱动装置5)。Fig. 2 - schematic diagram of drum spinning collection device in the present invention (insulated high-speed drum 6, high-speed motor 7, high-voltage power supply 3, spinning solution 4, driving device 5).
具体实施方式 Detailed ways
纳米纤维支架是近年来兴起的一种细胞培养基质,该纳米超级有序纤维支架直径范围在50nm-500nm之间,孔隙率>90%,且孔隙在三维方向上相互贯通。静电纺丝技术得到的三维纳米多孔聚合物支架在结构上与天然细胞外基质(ECM)更接近,有利于细胞的黏附生长,并且纳米纤维支架中极小的三维空隙促进细胞在生长过程中产生相互的影响,利于细胞的分化、繁殖。因此该纳米超级有序纤维支架可以提供给细胞一个更好的微环境,实现真正意义上的细胞三维生长。The nanofibrous scaffold is a kind of cell culture substrate emerging in recent years. The nanometer super ordered fiber scaffold has a diameter ranging from 50nm to 500nm, a porosity of >90%, and pores interconnected in three-dimensional directions. The three-dimensional nanoporous polymer scaffold obtained by electrospinning technology is closer in structure to the natural extracellular matrix (ECM), which is conducive to the adhesion and growth of cells, and the extremely small three-dimensional voids in the nanofibrous scaffold promote the formation of cells during the growth process. Mutual influence is conducive to cell differentiation and reproduction. Therefore, the nano-super-ordered fiber scaffold can provide cells with a better microenvironment and realize the true three-dimensional growth of cells.
利用静电纺丝技术将左旋聚乳酸制备成纳米超级有序纤维支架材料,依据上述纳米有序纤维支架和左旋聚乳酸的优点,可以相信纳米PLLA超级有序膜支架材料在组织工程领域具有广阔的应用前景。Using electrospinning technology to prepare L-polylactic acid into a nano-ordered super-ordered fiber scaffold material, based on the advantages of the above-mentioned nano-ordered fiber scaffold and L-polylactic acid, it can be believed that the nano-PLLA super-ordered membrane scaffold material has broad applications in the field of tissue engineering. Application prospects.
实施例1:Example 1:
1.纺丝溶液的制备:将左旋聚乳酸(PLLA)溶解于二氯甲烷与二甲基甲酰胺(体积比=3∶1)的混合溶液中,磁力搅拌两小时后用5000rap/min离心以去除溶液中的气泡,即能得到均匀、稳定的纺丝溶液。1. Preparation of spinning solution: Dissolve L-polylactic acid (PLLA) in a mixed solution of dichloromethane and dimethylformamide (volume ratio = 3: 1), magnetically stir for two hours and centrifuge at 5000 rap/min to obtain By removing the air bubbles in the solution, a uniform and stable spinning solution can be obtained.
2.纳米纤维膜的制备:如图1所示,将上述左旋聚乳酸溶液置于驱动装置5中,5ml的玻璃注射器中(6号针头),在针头处加10kv的高压电源3,以0.5ml/h的速度推进玻璃注射器中的左旋聚乳酸溶液,利用平板接收器1作为纳米纤维的收集装置,收集装置与针头间的距离保持在15-20cm之间。将制备的左旋聚乳酸纳米超级有序纤维膜保存在室温下真空干燥以备用。2. Preparation of nanofiber membrane: as shown in Figure 1, the above-mentioned L-polylactic acid solution is placed in the driving device 5, in the glass syringe of 5ml (No. Propel the poly-L-lactic acid solution in the glass syringe at a speed of ml/h, use the flat receiver 1 as a collection device for nanofibers, and keep the distance between the collection device and the needle at 15-20 cm. The prepared L-polylactic acid nano-super ordered fiber membrane was stored at room temperature and dried under vacuum for future use.
3.纳米纤维支架材料的改性处理:将步骤2中所得的纳米超级有序纤维材料利用低温等离子体技术改性及I型胶原表面涂覆,将制备的纤维样品放入自制等离子体处理仪中(外电极,电极间距为6cm),配备SY型晶控射频功率源(300W,北京微电子中心),反应条件设定为:放电功率40W,NH3气流量20ml/min,压力20Pa,处理时间40S。将等离子体处理过的纤维样品浸入浓度为3mg/ml的I型胶原(美国,Sigma公司)溶液反应24h,反复用去离子水清洗后浸泡24h以除去表面物理吸附的胶原蛋白,将左旋聚乳酸电纺纤维裁减成15mm×15mm大小的膜真空干燥备用。3. Modification of nanofibrous scaffold materials: the nano-super ordered fiber material obtained in step 2 is modified by low-temperature plasma technology and coated with type I collagen, and the prepared fiber samples are placed in a self-made plasma processor Middle (outer electrodes, electrode spacing is 6cm), equipped with SY type crystal-controlled RF power source (300W, Beijing Microelectronics Center), the reaction conditions are set as: discharge power 40W, NH 3 gas flow rate 20ml/min, pressure 20Pa, treatment Time 40S. The plasma-treated fiber samples were immersed in a solution of type I collagen (Sigma, USA) with a concentration of 3 mg/ml to react for 24 h, washed with deionized water repeatedly and soaked for 24 h to remove the physically adsorbed collagen on the surface, and the poly-L-lactic acid The electrospun fiber was cut into a film with a size of 15mm×15mm and dried in vacuum for later use.
实施例2:Example 2:
1.如实施例1中的步骤1。1. As in step 1 in Example 1.
2.纳米纤维膜的制备:如图2所示,将上述左旋聚乳酸溶液置于5ml的玻璃注射器中(6号针头),在针头处加10kv的高电压,以0.5ml/h的速度推进玻璃注射器中的左旋聚乳酸溶液,利用高速马达7的高速旋转,绝缘高速(金属丝)滚筒6接收器1000r/min作为纳米纤维的收集装置,收集装置与针头间的距离保持在15-20cm之间。将制备的左旋聚乳酸纳米超级有序纤维膜保存在室温下真空干燥以备用。2. Preparation of nanofiber membrane: as shown in Figure 2, place the above-mentioned L-polylactic acid solution in a 5ml glass syringe (No. 6 needle), apply a high voltage of 10kv to the needle, and advance at a speed of 0.5ml/h The L-polylactic acid solution in the glass syringe utilizes the high-speed rotation of the high-speed motor 7, and the insulated high-speed (wire) roller 6 receiver 1000r/min is used as a collection device for nanofibers, and the distance between the collection device and the needle remains between 15-20cm between. The prepared L-polylactic acid nano-super ordered fiber membrane was stored at room temperature and dried under vacuum for future use.
3.纳米纤维支架材料的改性处理:如实施例1中的步骤3。3. Modification of nanofibrous scaffold material: as step 3 in Example 1.
实施例3:Example 3:
1.如实施例1中的步骤1。1. As in step 1 in Example 1.
2.纳米纤维膜的制备:如图2所示,将上述左旋聚乳酸溶液置于5ml的玻璃注射器中(6号针头),在针头处加10kv的高电压,以0.5ml/h的速度推进玻璃注射器中的左旋聚乳酸溶液,利用高速马达7的高速旋转,绝缘高速(金属丝)滚筒6接收器以2000r/min作为纳米纤维的收集装置,收集装置与针头间的距离保持在15-20cm之间。将制备的左旋聚乳酸纳米超级有序纤维膜保存在室温下真空干燥以备用。2. Preparation of nanofiber membrane: as shown in Figure 2, place the above-mentioned L-polylactic acid solution in a 5ml glass syringe (No. 6 needle), apply a high voltage of 10kv to the needle, and advance at a speed of 0.5ml/h The L-polylactic acid solution in the glass syringe utilizes the high-speed rotation of the high-speed motor 7, and the insulated high-speed (wire) roller 6 receiver is used as a collection device for nanofibers at 2000r/min, and the distance between the collection device and the needle remains at 15-20cm between. The prepared L-polylactic acid nano-super ordered fiber membrane was stored at room temperature and dried under vacuum for future use.
3.纳米纤维支架材料的改性处理:如实施例1中的步骤3。3. Modification of nanofibrous scaffold material: as step 3 in Example 1.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810235160 CN101401955A (en) | 2008-11-14 | 2008-11-14 | Method for producing nano-fibre bracket material with levorotation polylactic acid as base material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810235160 CN101401955A (en) | 2008-11-14 | 2008-11-14 | Method for producing nano-fibre bracket material with levorotation polylactic acid as base material |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101401955A true CN101401955A (en) | 2009-04-08 |
Family
ID=40536203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810235160 Pending CN101401955A (en) | 2008-11-14 | 2008-11-14 | Method for producing nano-fibre bracket material with levorotation polylactic acid as base material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101401955A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103418026A (en) * | 2013-08-26 | 2013-12-04 | 苏州大学 | Suspending skin tissue engineering nanofiber support and preparation method thereof |
CN103877622A (en) * | 2014-03-26 | 2014-06-25 | 中山大学 | Electrostatic spinning nanofiber-extracellular matrix composite material as well as preparation method and application thereof |
CN104120500A (en) * | 2013-04-23 | 2014-10-29 | 上海交通大学医学院附属第九人民医院 | Fish collagen/mesoporous bioglass composite nanofiber membrane and making method thereof |
CN104213331A (en) * | 2014-09-12 | 2014-12-17 | 天津工业大学 | Preparation method of electrostatic spinning polylactic acid nano-pore fiber membrane |
CN104258472A (en) * | 2014-09-18 | 2015-01-07 | 郭玉臣 | Preparation method of anti-adhesive membrane used after neurosurgical operations |
WO2015155182A1 (en) | 2014-04-10 | 2015-10-15 | Purac Biochem Bv | Poly(lactic) membrane and method of making the membrane |
CN105396181A (en) * | 2015-08-24 | 2016-03-16 | 武汉医佳宝生物材料有限公司 | Degradable scaffold medical film preparation method |
CN105597162A (en) * | 2015-12-30 | 2016-05-25 | 广州迈普再生医学科技有限公司 | Nanofiber tissue filler and preparing method thereof |
CN107469143A (en) * | 2017-08-28 | 2017-12-15 | 昆明医科大学第附属医院 | A kind of nano material for promoting bone cell growth and its preparation method and application |
CN108049028A (en) * | 2017-12-18 | 2018-05-18 | 河北工业大学 | A kind of preparation method of collagen-based electrospinning fibre carrier |
CN110694115A (en) * | 2019-10-22 | 2020-01-17 | 上海交通大学医学院附属第九人民医院 | Method for constructing tendon tissue in vitro, and biological material and application thereof |
CN110787661A (en) * | 2018-08-01 | 2020-02-14 | 台鉅生技股份有限公司 | Polymer-collagen composite membrane and its manufacturing method |
CN111188102A (en) * | 2020-02-18 | 2020-05-22 | 中山大学附属第六医院 | Preparation method of composite electrospun tissue engineering scaffold material, engineering scaffold material and application thereof |
CN114796263A (en) * | 2022-05-17 | 2022-07-29 | 中国人民解放军东部战区总医院 | Sodium hyaluronate hydrogen sustained-release solution and preparation method and application thereof |
-
2008
- 2008-11-14 CN CN 200810235160 patent/CN101401955A/en active Pending
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104120500A (en) * | 2013-04-23 | 2014-10-29 | 上海交通大学医学院附属第九人民医院 | Fish collagen/mesoporous bioglass composite nanofiber membrane and making method thereof |
CN103418026B (en) * | 2013-08-26 | 2015-01-14 | 苏州大学 | Suspending skin tissue engineering nanofiber support and preparation method thereof |
CN103418026A (en) * | 2013-08-26 | 2013-12-04 | 苏州大学 | Suspending skin tissue engineering nanofiber support and preparation method thereof |
CN103877622B (en) * | 2014-03-26 | 2016-04-20 | 中山大学 | A kind of Electrospun nano-fibers-ECM coupled biomaterial and its preparation method and application |
CN103877622A (en) * | 2014-03-26 | 2014-06-25 | 中山大学 | Electrostatic spinning nanofiber-extracellular matrix composite material as well as preparation method and application thereof |
US10443154B2 (en) | 2014-04-10 | 2019-10-15 | Purac Biochem B.V. | Poly(lactic acid) membrane and method of making the membrane |
US11970790B2 (en) | 2014-04-10 | 2024-04-30 | Purac Biochem B.V. | Poly(lactic acid) membrane and method of making the membrane |
WO2015155182A1 (en) | 2014-04-10 | 2015-10-15 | Purac Biochem Bv | Poly(lactic) membrane and method of making the membrane |
CN104213331A (en) * | 2014-09-12 | 2014-12-17 | 天津工业大学 | Preparation method of electrostatic spinning polylactic acid nano-pore fiber membrane |
CN104258472A (en) * | 2014-09-18 | 2015-01-07 | 郭玉臣 | Preparation method of anti-adhesive membrane used after neurosurgical operations |
CN105396181A (en) * | 2015-08-24 | 2016-03-16 | 武汉医佳宝生物材料有限公司 | Degradable scaffold medical film preparation method |
CN105597162A (en) * | 2015-12-30 | 2016-05-25 | 广州迈普再生医学科技有限公司 | Nanofiber tissue filler and preparing method thereof |
CN105597162B (en) * | 2015-12-30 | 2018-12-21 | 广州迈普再生医学科技股份有限公司 | A kind of nano fibrous tissue filler and preparation method thereof |
CN107469143A (en) * | 2017-08-28 | 2017-12-15 | 昆明医科大学第附属医院 | A kind of nano material for promoting bone cell growth and its preparation method and application |
CN108049028B (en) * | 2017-12-18 | 2020-05-22 | 河北工业大学 | A kind of preparation method of collagen-based electrospun fiber antibacterial agent carrier |
CN108049028A (en) * | 2017-12-18 | 2018-05-18 | 河北工业大学 | A kind of preparation method of collagen-based electrospinning fibre carrier |
CN110787661A (en) * | 2018-08-01 | 2020-02-14 | 台鉅生技股份有限公司 | Polymer-collagen composite membrane and its manufacturing method |
CN110694115A (en) * | 2019-10-22 | 2020-01-17 | 上海交通大学医学院附属第九人民医院 | Method for constructing tendon tissue in vitro, and biological material and application thereof |
CN110694115B (en) * | 2019-10-22 | 2022-03-01 | 上海交通大学医学院附属第九人民医院 | Method for constructing tendon tissue in vitro, and biological material and application thereof |
CN111188102A (en) * | 2020-02-18 | 2020-05-22 | 中山大学附属第六医院 | Preparation method of composite electrospun tissue engineering scaffold material, engineering scaffold material and application thereof |
CN114796263A (en) * | 2022-05-17 | 2022-07-29 | 中国人民解放军东部战区总医院 | Sodium hyaluronate hydrogen sustained-release solution and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101401955A (en) | Method for producing nano-fibre bracket material with levorotation polylactic acid as base material | |
Sheikh et al. | 3D electrospun silk fibroin nanofibers for fabrication of artificial skin | |
CN105107022B (en) | A kind of preparation method of the nanofiber porous support with the elasticity of compression under hygrometric state | |
CN103341209B (en) | Silk fibroin nanofiber membrane and preparation method thereof | |
Fujita et al. | Geometrically customizable alginate hydrogel nanofibers for cell culture platforms | |
CN100493626C (en) | A kind of cell culture support material and preparation method thereof | |
CN102277737A (en) | Preparation method and application of polycaprolactone/natural high-molecular composite porous scaffold | |
CN106267339B (en) | A kind of super hydrophilic biological support preparation method of high-modulus | |
CN100394988C (en) | A preparation method of natural nanofiber-based tissue engineering cell scaffold | |
CN103736153A (en) | Single-layer and double-layer polycaprolactone-based guided tissue regeneration membranes and preparation method thereof | |
CN102357264B (en) | Silk fibroin porous material and preparation method thereof and tissue engineering stent | |
CN101780292B (en) | Three-dimensional porous nano-bracket based on fibrinogen and preparation method thereof | |
CN103225126B (en) | Fibroin/sodium alginate composite nanofiber scaffold preparation method | |
CN104001208B (en) | Preparation method for biomacromolecule/chitin nanocrystalline composite scaffold material | |
CN113046926B (en) | Silk fibroin polylactic acid porous nanofiber composite material and preparation method and application thereof | |
CN110453378A (en) | A kind of sulfonic acid group quantum dot/silk fibroin composite nanofiber membrane and its preparation method and application | |
CN102102278A (en) | Preparation method of silk fibroin-poly(hydroxybutyrate-hydroxyvalerate) composite fiber membrane | |
CN101844406A (en) | Device and method for manufacturing micro-nano porous structure | |
CN104667351A (en) | Nerve growth factor loaded silk fibroin nanofiber scaffold and preparation method | |
CN107670115A (en) | Fibroin albumen/hydroxyapatite/poly-(Racemic lactic acid co caprolactones)The preparation method of composite nano-fiber membrane | |
CN106139246A (en) | A kind of regenerated silk azelon support and preparation method thereof | |
CN106798948A (en) | A kind of method of regulation and control biofilm surface topological structure to promote cell to creep | |
CN101736438B (en) | Chitosan nanofibre and preparation method and application thereof | |
CN111472093A (en) | Nano-hydroxyapatite/polylactic acid composite fiber membrane and preparation method thereof | |
CN114632189A (en) | Elastic porous scaffold and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20090408 |